Optaflu influenza vaccine, receives support of European Union approval
EU Regulation and Influenza Vaccines
Novartis leading the introduction of influenza cell culture manufacturing - the first major innovation in influenza vaccine manufacturing in more than 50 years.
Share this content.
If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.